AI is transforming the field of drug discovery by accelerating the identification of potential new treatments. Traditional drug discovery is a lengthy and expensive process, but AI can analyze vast amounts of biological data to identify promising drug candidates much more quickly. AI algorithms can predict how different drugs will interact with cancer cells, thereby identifying the most promising compounds for further testing. Companies like BenevolentAI and Insilico Medicine are at the forefront of using AI for drug discovery in oncology.
